Hepatitis-associated antigen

Identifieur interne : 001F61 ( Main/Exploration ); précédent : 001F60; suivant : 001F62

---

Hepatitis-associated antigen

Auteurs : N. Raphael Shulman [États-Unis]

Source :

• The American Journal of Medicine [ 0002-9343 ] ; 1970.

RBID : ISTEX:A510384C2068EBC8E17BC46D8F8693322E4523C3

English descriptors

• Teeft :
  • Abnormal liver function tests, Active hepatitis, Acute hepatitis, Acute phase, Acute phase serum, Additional observations, Additional patients, Agar, Agarose, Agglutinated cells, Agglutinates cells, Amer, American journal, Anamnestic, Anamnestic antibody responses, Anamnestic response, Anicteric, Anicteric hepatitis, Antecedent episode, Antibody, Anticomplementary, Anticomplementary activity, Antigen, Antigenic, Antigenic determinants, Antigenic serum, Antiserum, Apparent transmission, Arthritis rheum, Assay, Australia antigen, Autosomal recessive inheritance, Biliary, Biliary cirrhosis, Blood banks, Blood donors, Blood products, Blumberg, Carrier state, Cesium, Cesium chloride, Cesium chloride gradient, Cesium chloride gradients, Chemical characteristics, Chimpanzee, Chronic hepatitis, Chronic liver disease, Cirrhosis, Clinical evidence, Complement, Complement fixation, Complement fixation procedures, Complement fixation technic, Complement fixation technics, Complement fixation tests, Complete virus, Cord blood, Counterelectrophoresis, Different sources, Differential rate sedimentation, Diffusion technic, Donor, Dos, Electron micrographs, Electron microscopy, Epidemiologic studies, Ether treatment, Experimental medicine, Factor viii, Filamentous forms, First peak, Fixation, Fluorescent antibody technic, Gamma globulin, Gocke, Guinea pigs, Haapositive hepatitis, Hemagglutination, Hemagglutination assay, Hemagglutination test, Hepatitis, Hepatitis agent, Hepatitis carriers, Hepatitis patients, Hepatitis recovery phase, Hepatitis virus, High concentration, High degree, High frequency, High quality complement fixation antibodies, High titer, High voltage, Higher apes, Histologic evidence, Host response, Human beings, Human hepatitis, Human plasma, Immune, Immune complexes, Immunodiffusion, Immunodiffusion technics, Immunodiffusion test, Immunodiffusion tests, Immunologic, Incubation, Incubation period, Indicator cells, Infectious agent, Infectious hepatitis, Infectious serum, Infectious virion, Infectious virus, Infectivity, Inoculated, Inoculated materials, Insensitive agar, Institutional transmission, Intimate contact, Kavey, Krugman, Laboratory evidence, Lancet, Large amounts, Lepromatous, Lepromatous leprosy, Leprosy, Lipid, Liver cells, Liver disease, Liver function tests, Liver lesions, Long period, Longincubation hepatitis, Many carriers, Many cases, Many months, Many patients, Many years, Marmoset monkeys, Mental retardation, Microtiter plates, Millman, Modal diameter, Month period, Morphologic characteristics, Multiple transfusions, Murakami, Nonhuman primates, Normal gamma globulin, Normal subjects, November, Okochi, Organic solvents, Other investigators, Other patients, Outer coat, Parenteral, Parenteral exposure, Particles aggregated, Patients antibody, Peak titer, Person contact, Person spread, Personal communication, Personal observations, Phase serum, Physical properties, Positive lupus erythematosus cell test, Positive reactions, Positive test, Positive tests, Postnecrotic cirrhosis, Precipitin, Precipitin line, Precipitin lines, Precipitin technics, Primary biliary cirrhosis, Primates, Radioimmunoassay, Rapid detection, Reagent, Renal dialysis units, Retarded patients, Right wells, Room temperature, Same patients, Same sensitivity, Screening blood donors, Second passage, Sensitive tests, Serum, Serum filtrates, Serum hepatitis, Serum hepatitis agent, Serum hepatitis virus, Serum samples, Serum specimens, Sgot values, Sgpt levels, Shulman, Significant difference, Small amounts, Small virus, Small viruses, Spherical particles, Staff members, Subacute hepatic necrosis, Subclinical hepatitis, Syndrome, Table viii, Technic, Technics, Test serum, Tissue culture, Titer, Total volume, Transfusion, Transmission experiments, Transplacental transmission, Tropical populations, Tuberculoid leprosy, Tubular forms, Undiluted plasma, Usual manifestations, Various observations, Various technics, Viral, Viral dose, Viral hepatitis, Viruslike particles, Weekly intervals.

Url:

• https://api.istex.fr/ark:/67375/6H6-GT4R8N7M-N/fulltext.pdf

DOI: 10.1016/S0002-9343(70)80133-4

Affiliations:

• États-Unis
• Maryland

---

Links toward previous steps (curation, corpus...)

• to stream Istex, to step Corpus: 000907
• to stream Istex, to step Curation: 000873
• to stream Istex, to step Checkpoint: 000888
• to stream Main, to step Merge: 001F92
• to stream Main, to step Curation: 001F61

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F61 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A510384C2068EBC8E17BC46D8F8693322E4523C3
   |texte=   Hepatitis-associated antigen
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021